MEDICUS PHARMA LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.99 CAD | -0.50% |
|
+2.05% | -0.50% |
| 29/05 | Medicus Pharma Files Registration Statement for Proposed Initial Public Offering in the United States | MT |
| 25/04 | Medicus Pharma Ltd. announced a financing transaction | CI |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Capitalization 1 | 32.15 | 32.15 | - |
| Enterprise Value (EV) 1 | 32.15 | 32.15 | 32.15 |
| P/E ratio | - | - | - |
| Yield | - | - | - |
| Capitalization / Revenue | - | - | - |
| EV / Revenue | - | - | - |
| EV / EBITDA | - | - | - |
| EV / FCF | - | -44.4 x | -41.9 x |
| FCF Yield | - | -2.25% | -2.38% |
| Price to Book | - | - | - |
| Nbr of stocks (in thousands) | 16,153 | 16,153 | - |
| Reference price 2 | 1.990 | 1.990 | 1.990 |
| Announcement Date | - | - | - |
1CAD in Million2
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net sales 1 | - | - | - |
| EBITDA | - | - | - |
| EBIT | - | - | - |
| Operating Margin | - | - | - |
| Earnings before Tax (EBT) | - | - | - |
| Net income | - | - | - |
| Net margin | - | - | - |
| EPS | - | - | - |
| Free Cash Flow | - | -7,24,224 | -7,66,435 |
| FCF margin | - | - | - |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | - | - | - |
1CAD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Debt | - | - | - |
| Net Cash position | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - |
| Free Cash Flow | - | -7,24,224 | -7,66,435 |
| ROE (net income / shareholders' equity) | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - |
| Assets | - | - | - |
| Book Value Per Share | - | - | - |
| Cash Flow per Share | - | - | - |
| Capex | - | - | - |
| Capex / Sales | - | - | - |
| Announcement Date | - | - | - |
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -0.50% | 2.36Cr | |
| +40.73% | 74TCr | |
| +32.83% | 60TCr | |
| -6.30% | 35TCr | |
| +15.15% | 32TCr | |
| +4.05% | 28TCr | |
| +15.00% | 24TCr | |
| -5.52% | 21TCr | |
| +6.17% | 16TCr | |
| -0.45% | 16TCr |
- Stock Market
- Equities
- MDCX Stock
- Financials Medicus Pharma Ltd.
